Studies have shown TAMs and MDSCs to constitute a large proportion of tumor infiltrating immune cells in the GBM tumor microenvironment (TME) (7), ranging from 30 to 90% in human GBM samples, with CD11b+ MDSCs comprising the majority of infiltrating inflammatory cells in human gliomas (8, 9). This evidence concerns the gene ITGAM and glioblastoma.